Medication Assisted Treatment of Opioid Addiction using Buprenorphine (6 hours)

Categories: Medication | Opioid | Treatment
Learning Objectives

Upon completion of this course, participants will be able to:

• Describe the pharmacological profile of buprenorphine, including its mechanism of action, formulations, and clinical effectiveness in treating opioid addiction.
• Apply screening and assessment procedures to evaluate patients with opioid addiction for buprenorphine treatment.
• Determine the appropriateness of buprenorphine treatment based on patient history, severity of addiction, and clinical criteria.
• Outline buprenorphine treatment protocols, including induction, stabilization, and maintenance phases.
• Identify the policies, procedures, and regulatory requirements governing the use of buprenorphine in opioid addiction treatment.
• Describe treatment considerations for special populations, including pregnant women, adolescents, geriatric patients, and individuals with psychiatric comorbidity.
• Explain strategies for managing patients with polysubstance abuse and co-occurring pain conditions during buprenorphine treatment.
• Analyze the current state of opioid addiction treatment in the United States and the role of buprenorphine within the continuum of care.
• Assess for the presence of co-occurring medical and psychiatric conditions that may affect buprenorphine treatment outcomes.

Robert A. Shearer

Robert A. Shearer

Ph. D

Dr. Robert A. Shearer is a retired professor of Criminal Justice, Sam Houston State University. He received his Ph.D. in Counseling and Psychology from Texas A & M University, Commerce. Prior to teaching Criminal Justice, he taught Educational Psychology at Mississippi State University on campus and in the extension program across rural Mississippi during the civil rights era.

He has been teaching, training, consulting and conducting research in the fields of Criminal Justice, human behavior, and addictions for over thirty-six years. He is the author of over sixty professional and refereed articles in Criminal Justice and behavior. He is also the author of Interviewing: Theories, techniques, and practices, 5th edition published by Prentice Hall. Dr. Shearer has also created over a dozen measurement, research, and assessment instruments in Criminal Justice and addictions.

He has been a psychotherapist in private practice and served as a consultant to dozens of local, state, and national agencies. His interests continue to be substance abuse program assessment and evaluation. He has taught courses in interviewing, human behavior, substance abuse counseling, drugs-crime-social policy, assessment and treatment planning, and educational psychology. He has also taught several university level psychology courses in the Texas Department of Criminal Justice Institutional Division, led group therapy in prison, trained group therapists, and served as an expert witness in various courts of law.

He has been the president of the International Association of Addictions and Offender Counseling and the editor of the Journal of Addictions and Offender Counseling as well as a member of many Criminal Justice, criminology, and counseling professional organizations prior to retirement.

   

Approved and Widely Recognized

CEU Matrix is approved by the following national and state accreditation boards:

Provider #6310
Provider #94564

CEU Matrix is approved with the following state boards:

Arkansas (ASACB), California (CCAPP #OS-07-394-0222), California (CADTP #250), Connecticut (#0115-5202), Delaware (DCB #37), Florida (FCB #5141-A), Georgia (ADACBGA #2026-4-003), Illinois (IAODAPCA #19345), Kentucky, Louisiana (LA ADRA #E026), Michigan (MCBAP), Missouri (Missouri CB #183), New Mexico (NMCBBHP #2046), North Carolina (NCSAPPB), Ohio (OCDP #50-19236), Oklahoma (OBLADS #20260153), Texas (TCB #1758-07)

Recently Viewed

Ohio LICDC partial
$313.00
Ohio 30
$210.00
LA CIT
$221.00
Scroll to Top